S.M. Bester
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 3
-
- Cholinesterase and Neurodegenerative Diseases 4
- Co-authors
- Mamuka Kvaratskhelia (4 shared papers)Guochao Wei (4 shared papers)Arun S. Annamalai (4 shared papers)Daniel Adu‐Ampratwum (2 shared papers)James R. Fuchs (2 shared papers)Alan Engelman (3 shared papers)Ashwanth C. Francis (3 shared papers)Parmit K. Singh (3 shared papers)
- Journals
- mBio (2 papers)Chemical Research in Toxicology (2 papers)Nature Communications (1 paper)ACS Infectious Diseases (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
S.M. Bester
11 papers receiving 313 citations
Peers
Comparison fields: 5 of 46
- Virology 168
- Infectious Diseases 150
- Pharmacology 53
- Structural Biology 3
- Hepatology 14
Countries citing papers authored by S.M. Bester
This map shows the geographic impact of S.M. Bester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Bester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Bester more than expected).
Fields of papers citing papers by S.M. Bester
This network shows the impact of papers produced by S.M. Bester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Bester. The network helps show where S.M. Bester may publish in the future.
Co-authors
The 25 scholars most cited alongside S.M. Bester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 163 | |
| 2 | 2018 | 44 | |
| 3 | 2022 | 34 | |
| 4 | 2022 | 28 | |
| 5 | 2019 | 12 | |
| 6 | 2018 | 11 | |
| 7 | 2021 | 10 | |
| 8 | 2019 | 7 | |
| 9 | 2025 | 6 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 |
About S.M. Bester
S.M. Bester is a scholar working on Infectious Diseases, Pharmacology, Virology, Plant Science and Molecular Biology, having authored 11 papers that have together received 317 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (4 papers), Pesticide Exposure and Toxicity (4 papers), HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers), Computational Drug Discovery Methods (3 papers), Cytomegalovirus and herpesvirus research (1 paper), Virus-based gene therapy research (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Virology (168 citations), Infectious Diseases (150 citations), Pharmacology (53 citations), Structural Biology (3 citations) and Hepatology (14 citations). S.M. Bester has collaborated with scholars based in United States and India. Frequent co-authors include Mamuka Kvaratskhelia, Guochao Wei, Arun S. Annamalai, Daniel Adu‐Ampratwum, James R. Fuchs, Alan Engelman, Ashwanth C. Francis, Parmit K. Singh, Scott D. Pegan and Nikoloz Shkriabai. Their work appears in journals such as mBio, Chemical Research in Toxicology, Nature Communications, ACS Infectious Diseases and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.